Educational Series – VISIBLE: First study for patients with plaque psoriasis and skin of colour

We’re delighted to add our latest Educational Series titled: VISIBLE: First study for patients with plaque psoriasis and skin of colour. This Educational Review discusses the VISIBLE study (Varying Skin Tones in Body and Scalp Psoriasis: Guselkumab Efficacy and Safety), the first prospective, randomised clinical trial to include participants with moderate-to-severe plaque psoriasis representing the full range of objectively measured skin tones.

It also includes guiding commentary from Associate Professor Michelle Rodrigues, a Melbourne-based dermatologist and founder and director of Chroma Dermatology, a specialist centre for advancing care for skin of colour and a consultant at The Royal Children’s Hospital and the Skin Health Institute.